Hyoung Jin Kang, MD, PhD, associate professor, Department of Pediatrics, Seoul National University, South Korea, discusses a phase III trial of aprepitant for chemotherapy-induced nausea and vomiting (CINV) in children.
Hyoung Jin Kang, MD, PhD
Advertisement
Articles by Hyoung Jin Kang, MD, PhD
Advertisement
Latest Updated Articles
Dr. Kang on Aprepitant for Preventing CINV in ChildrenPublished: July 3rd 2014 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
T-DXd Plus Pertuzumab Sustains PFS Benefit Across HER2+ BC Subgroups
2
Sacituzumab Govitecan/Pembro Maintains QOL, Physical Functioning in mTNBC
3
VCN-01 Plus SOC Improves Survival, Is Safe in Metastatic PDAC
4
Buparlisib/Chemo Combo Misses OS Mark in PD-1–Treated Recurrent HNC
5
